Events & Presentations
No webcasts scheduled. Check back soon.
AMT-130 12-Month Low-Dose Cohort Update – Investor Webcast PresentationView Presentation
EAHAD 2022 – Final Analysis from the Pivotal Phase 3 HOPE-B Gene Therapy Trial: Stable Steady-State Efficacy and Safety of Etranacogene Dezaparvovec in Adults with Severe or Moderately Severe Hemophilia BView Presentation
2021 Dutch Statutory IFRS FinancialsView Presentation
ISTH 2021 – Clinical Outcomes in Adults with Hemophilia B With Pre-existing Neutralizing Antibodies to AAV5: 6 Month Data from the HOPE-B TrialView Presentation
Gene Therapy InformationView Presentation